Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Female-Specific Modifiers for Healthy Early Action in Cardiovascular Risk Trajectories

NCT07703124 is registered in ClinicalTrials.gov with Ludwig Boltzmann Institute for Cardiovascular Research as lead sponsor.

NCT NCT07703124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07703124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Female-Specific Modifiers for Healthy Early Action in Cardiovascular Risk Trajectories
Lead sponsor
Ludwig Boltzmann Institute for Cardiovascular Research
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2027
Completion date
October 31, 2031
Enrollment
605 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular (cv) risk, perimenopausal women, postmenopausal female patients